Global Commercial Pharmaceutical Analytics Market Research Report- Forecast to 2027

Global Commercial Pharmaceutical Analytics Market Research Report- Forecast to 2027

ID: MRFR/HCIT/0332-CRR | October, 2016 | Region: Global | 85 pages | Cooked Research Reports

Global Commercial Pharmaceutical Analytics Market Information, by Types (Prescriptive, Descriptive, Predictive), by Deployment (Cloud, Web Based), by Applications (R&D, Marketing & Sales, Supply Chain Optimizations) - Forecast To 2027


Market Synopsis of Commercial Pharmaceutical Analytics Market:


Market Scenario:


Globally the market for commercial pharmaceutical analytics is increasing rapidly. The major factor that drives the growth of commercial pharmaceutical analytics is growing adoption of new technologies and analytical tools, increasing usage of analytical tools to streamline the business process, growing pharmaceutical industry and others.


Globally the market for commercial pharmaceutical analytics market is expected to grow at the rate of about 20.0% from 2016 to 2027.

Global Commercial Pharmaceutical Analytics Market Share (2015)

Global Commercial Pharmaceutical Analytics Market Share (2015)


Study Objectives of Commercial Pharmaceutical Analytics Market:



  • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the commercial pharmaceutical analytics market  

  • To provide insights about factors affecting the market growth

  • To analyze the commercial pharmaceutical analytics market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type, by component, by applications and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global market


Intended Audience



  • Healthcare & Life Science Analytics Software Companies

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Academic Medical Institutes and Universities

  • Hospitals & Clinics


Key Finding



  • The global commercial pharmaceutical analytics market and is expected to reach $9,308.4 million by 2027.

  • Descriptive analytics accounted for the largest market share registering 78.34% of market share in 2015

  • Regionally, North America holds the largest market share 48.6% of global commercial pharmaceutical analytics market and is expected to reach $4,299 million by 2027 from $507.4 million in 2015.

  • Asia Pacific market is expected to be the fastest growing market, and expected to grow at a CAGR of 20.8% from 2016 to 2027

  • On the basis of applications, research & development segment holds 40.8% market share


Key Players for Commercial Pharmaceutical Analytics Market:               


Some of the key players in this market are: Allscripts (U.S), Microsoft (U.S), Wipro Limited (U.S), Statistical Analysis System (U.S), Northwest Analytics, INC. (U.S), International Business Machines Corporation (U.S), ORACLE (U.S), Citiustech INC (U.S), Scio Health Analytics (U.S), Take Solutions LTD (U.S), Trinity Pharma Solutions (U.S), Fuzzy Logix INC (U.S), and Cerner Corporation (U.S)


Segments:                                                                                                                                        


Global commercial pharmaceutical analytics market has been segmented on the basis of types which comprises of prescriptive analytics, descriptive analytics, and predictive analytics. On the basis of deployment the market is segmented into cloud based and web based. Furthermore, based on applications the market is segmented into R&D, marketing & sales, supply chain optimizations, internal reporting and others.


Regional Analysis of Commercial Pharmaceutical Analytics Market:                          


Globally, North America is the largest market for commercial pharmaceutical analytics.


Europe is the second-largest market for commercial pharmaceutical analytics. The market is anticipated to reach at $2,613.1 by 2027.


Due to the increasing adoption rate, Asia-pacific is estimated to be the fastest growing region globally, registering 20.8% CAGR during the forecast period.

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

2.1 Definition 17
2.2 Scope of Study 18
2.2.1 Research Objective 18
2.2.2 Assumptions & Limitations 18
2.2.2.1 Assumptions 18
2.2.2.2 Limitations 18
2.3 Market structure: 19

3.1 Introduction 20
3.2 Primary Research 21
3.3 Secondary research 21
3.4 Market Size Estimation 22

4.1 Drivers 24
4.1.1 Growing Adoption Of New Technologies and Analytical Tools 24
4.1.2 Regulation of R&D Productivity 24
4.1.3 Growing trend of the big data advertisement in Pharma sector. 25
4.1.4 Increasing Usage Of Analytical Tools In Streamlining Business Process 25
4.2 Restraint 26
4.2.1 lack of skilled professionals 26
4.2.2 Conservative Nature of Healthcare Industry. 26

5.1 Porter’s five forces model 27
5.1.1 Introduction 27
5.1.2 Bargaining power of suppliers 28
5.1.3 Bargaining power of Buyers: 28
5.1.4 Intensity of Competitor’s: 28
5.1.5 Threat of new entrants: 29
5.1.6 Threat from Substitutes 29
5.2 Value Chain Analysis 30
5.2.1 Inputs 31
5.2.2 Development Process 31
5.2.3 Output 31
5.2.4 Marketing and Distribution 31
5.2.5 Post Selling Services 31

6.1 Introduction 32
6.1.1 Descriptive Analytics 34
6.1.2 Predictive Analytics 34
6.1.3 Prescriptive Analytics 35

7.1 Introduction 37
7.2 R&D 39
7.2.1 Marketing & Sales 40
7.2.2 Supply Chain Optimization 40
7.2.3 Internal Reporting 41

9.1 Introduction 47
9.2 Software 49
9.3 Services 50

10.1 Introduction 51
10.2 Americas 53
10.2.1 North America 57
10.2.1.1 US 59
10.2.1.2 Canada 61
10.2.2 Latin America 63
10.3 Europe 65
10.3.1 Western Europe 69
10.3.1.1 Germany 69
10.3.1.2 France 71
10.3.1.3 UK 73
10.3.1.4 Italy 75
10.3.1.5 Spain 77
10.3.1.6 Rest of Western Europe 79
10.3.2 Eastern Europe 81
10.3.3 Asia Pacific 83
10.3.3.1 Japan 87
10.3.3.2 China 89
10.3.3.3 India 91
10.3.3.4 South Korea 93
10.3.3.5 Rest of Asia Pacific 95
10.3.4 Middle East & Africa 97

11.1 Introduction 101
11.1.1 Mergers Acquisitions 102
11.1.2 Collaborations 103
11.1.3 Release/New Product Launches 103
11.1.4 Other (Expansion, Updates, Partnership) 104

12.1 CitiusTech Inc. 106
12.1.1 Company Overview 106
12.1.2 Product/Business Segment Overview 106
12.1.3 Financial Overview 106
12.1.4 Key Development 106
12.2 International Business Machines Corporation 107
12.2.1 Company Overview 107
12.2.2 Product/Business Segment Overview 107
12.2.3 Financial Overview 108
12.2.4 Key Development 109
12.3 Northwest analytics, Inc. 110
12.3.1 Company Overview 110
12.3.2 Product/Business Segment Overview 110
12.3.3 Financial Overview 110
12.3.4 Key Development 110
12.4 ORACLE 111
12.4.1 Company Overview 111
12.4.2 Product/Business Segment Overview 111
12.4.3 Financial Overview 112
12.4.4 Key Development 113
12.5 SCIO HEALTH ANALYTICS 114
12.5.1 Company Overview 114
12.5.2 Product/Business Segment Overview 114
12.5.3 Financial Overview 114
12.5.4 Key Developments 115
12.6 Statistical Analysis System 116
12.6.1 Company Overview 116
12.6.2 Product/Business Segment Overview 116
12.6.3 Financial Overview 117
12.6.4 Key Development 118
12.7 TAKE Solutions Ltd 119
12.7.1 Company Overview 119
12.7.2 Product/Business Segment Overview 119
12.7.3 Financial Overview 120
12.7.4 Key Developments 121
12.8 Tata Consultancy Services Limited 122
12.8.1 Company Overview 122
12.8.2 Product/Business Segment Overview 122
12.8.3 Financial Overview 123
12.8.4 Key Development 124
12.9 TRINITY PHARMA SOLUTIONS 125
12.9.1 Company Overview 125
12.9.2 Product/Business Segment Overview 125
12.9.3 Financial Overview 125
12.9.4 Key Developments 125
12.10 Wipro Limited 126
12.10.1 Company Overview 126
12.10.2 Product/Business Segment Overview 126
12.10.3 Financial Overview 127
12.10.4 Key Development 128

13.1 Key Findings 129

TABLE 1 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 32
TABLE 2 GLOBAL DESCRIPTIVE ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 34
TABLE 3 GLOBAL PREDICTIVE ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 35
TABLE 4 GLOBAL PRESCRIPTIVE ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 36
TABLE 5 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY APPLICATION US$ MILLION 2014-2027 37
TABLE 6 GLOBAL RESEARCH & DEVELOPMENT IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 39
TABLE 7 GLOBAL MARKETING & SALES IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 40
TABLE 8 GLOBAL SUPPLY CHAIN IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 41
TABLE 9 GLOBAL INTERNAL REPORTING IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 42
TABLE 10 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 43
TABLE 11 ON PREMISE MODEL IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 45
TABLE 12 WEB BASED/CLOUD BASED MODEL IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 46
TABLE 13 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY COMPONENTS US$ MILLION 2014-2027 47
TABLE 14 GLOBAL SOFTWARE COMPONENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 49
TABLE 15 GLOBAL SERVICES COMPONENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 50
TABLE 16 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 51
TABLE 17 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 54
TABLE 18 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 55
TABLE 19 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATONS US$ MILLION 2014-2027 55
TABLE 20 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 56
TABLE 21 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 56
TABLE 22 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 57
TABLE 23 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 57
TABLE 24 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 58
TABLE 25 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014-2027 58
TABLE 26 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 59
TABLE 27 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 59
TABLE 28 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 60
TABLE 29 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 60
TABLE 30 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 61
TABLE 31 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 61
TABLE 32 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 62
TABLE 33 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 62
TABLE 34 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 63
TABLE 35 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 63
TABLE 36 ATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 64
TABLE 37 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 64
TABLE 38 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 66
TABLE 39 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 67
TABLE 40 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 67
TABLE 41 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 68
TABLE 42 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 68
TABLE 43 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 69
TABLE 44 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 69
TABLE 45 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 70
TABLE 46 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 70
TABLE 47 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 71
TABLE 48 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 71
TABLE 49 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 72
TABLE 50 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 72
TABLE 51 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 73
TABLE 52 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 73
TABLE 53 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 74
TABLE 54 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 74
TABLE 55 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 75
TABLE 56 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 75
TABLE 57 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 76
TABLE 58 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 76
TABLE 59 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 77
TABLE 60 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 77
TABLE 61 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 78
TABLE 62 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 78
TABLE 63 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 79
TABLE 64 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 79
TABLE 65 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 80
TABLE 66 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 80
TABLE 67 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 81
TABLE 68 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 81
TABLE 69 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 82
TABLE 70 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 82
TABLE 71 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 84
TABLE 72 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 85
TABLE 73 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 85
TABLE 74 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 86
TABLE 75 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 86
TABLE 76 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 87
TABLE 77 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 87
TABLE 78 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 88
TABLE 79 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 88
TABLE 80 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 89
TABLE 81 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 89
TABLE 82 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 90
TABLE 83 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 90
TABLE 84 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 91
TABLE 85 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 91
TABLE 86 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 92
TABLE 87 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 92
TABLE 88 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 93
TABLE 89 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 93
TABLE 90 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 94
TABLE 91 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 94
TABLE 92 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 95
TABLE 93 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 95
TABLE 94 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 96
TABLE 95 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 96
TABLE 96 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014 - 2027 97
TABLE 97 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 98
TABLE 98 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 99
TABLE 99 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 99
TABLE 100 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014 - 2027 100

FIGURE 2 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY TYPE, 2016 (%) 14
FIGURE 3 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY APPLICATION, 2016 (%) 14
FIGURE 4 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY DEPLOYMENT, 2016 (%) 15
FIGURE 5 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY COMPONENT, 2016 (%) 15
FIGURE 6 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY REGION, 2016 (%) 16
FIGURE 7 RESEARCH PROCESS 20
FIGURE 8 FORECAST MODEL 23
FIGURE 9 VALUE CHAIN ANALYSIS 30
FIGURE 10 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2016 & 2027 33
FIGURE 11 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY APPLICATION US$ MILLION 2016 & 2027 38
FIGURE 12 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2016 & 2027 44
FIGURE 13 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY COMPONENTS US$ MILLION 2014 & 2027 48
FIGURE 14 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014 - 2027 52
FIGURE 15 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2016 (%) 54
FIGURE 16 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2016 (%) 66
FIGURE 17 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2016 (%) 84
FIGURE 18 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014 - 2027 98
FIGURE 19 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE ANALYSIS 2016 (%) 101
FIGURE 20 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET COMPETITIVE ANALYSIS 2016 (%) 102
FIGURE 21 RECENT FINANCIALS 108
FIGURE 22 GEOGRAPHICAL REVENUE MIX, 2016 (%) 108
FIGURE 23 SEGMENTAL REVENUE MIX, 2016 (%) 109
FIGURE 24 RECENT FINANCIALS 112
FIGURE 25 GEOGRAPHICAL REVENUE MIX, 2016 (%) 112
FIGURE 26 SEGMENTAL REVENUE MIX, 2016 (%) 113
FIGURE 27 RECENT FINANCIALS 117
FIGURE 28 GEOGRAPHICAL REVENUE MIX, 2016 117
FIGURE 29 SEGMENTAL REVENUE MIX, 2016 118
FIGURE 30 RECENT FINANCIALS (USD MILLION) 120
FIGURE 31 GEOGRAPHIC REVENUE MIX, 2016 (%) 120
FIGURE 32 SEGMENTAL REVENUE MIX, 2016 (%) 121
FIGURE 33 RECENT FINANCIALS 123
FIGURE 34 GEOGRAPHICAL REVENUE MIX, 2016 (%) 123
FIGURE 35 SEGMENTAL MIX, 2016 (%) 124
FIGURE 36 RECENT FINANCIALS 127
FIGURE 37 GEOGRAPHICAL REVENUE MIX, 2016 (%) 127
FIGURE 38 SEGMENTAL REVENUE MIX, 2016 (%) 128